rs372521943
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_001099922.3(ALG13):āc.1064A>Gā(p.Gln355Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000249 in 1,203,755 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0000090 ( 0 hom., 1 hem., cov: 22)
Exomes š: 0.000027 ( 0 hom. 9 hem. )
Consequence
ALG13
NM_001099922.3 missense
NM_001099922.3 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: 5.10
Publications
1 publications found
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 36Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2679379).
BP6
Variant X-111717904-A-G is Benign according to our data. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496. Variant chrX-111717904-A-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 286496.
BS2
High Hemizygotes in GnomAdExome4 at 9 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111382Hom.: 0 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
111382
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000115 AC: 2AN: 173453 AF XY: 0.0000163 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
173453
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000265 AC: 29AN: 1092373Hom.: 0 Cov.: 28 AF XY: 0.0000251 AC XY: 9AN XY: 358073 show subpopulations
GnomAD4 exome
AF:
AC:
29
AN:
1092373
Hom.:
Cov.:
28
AF XY:
AC XY:
9
AN XY:
358073
show subpopulations
African (AFR)
AF:
AC:
0
AN:
26277
American (AMR)
AF:
AC:
0
AN:
34909
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19290
East Asian (EAS)
AF:
AC:
0
AN:
30159
South Asian (SAS)
AF:
AC:
0
AN:
53286
European-Finnish (FIN)
AF:
AC:
0
AN:
40395
Middle Eastern (MID)
AF:
AC:
0
AN:
4115
European-Non Finnish (NFE)
AF:
AC:
28
AN:
838040
Other (OTH)
AF:
AC:
1
AN:
45902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111382Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33554 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
111382
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33554
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30682
American (AMR)
AF:
AC:
0
AN:
10398
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2647
East Asian (EAS)
AF:
AC:
0
AN:
3562
South Asian (SAS)
AF:
AC:
0
AN:
2654
European-Finnish (FIN)
AF:
AC:
0
AN:
5912
Middle Eastern (MID)
AF:
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
AC:
1
AN:
53106
Other (OTH)
AF:
AC:
0
AN:
1497
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Mar 03, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 36 Benign:1
Aug 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;.;T;.;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;.;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N;.;.;.
REVEL
Benign
Sift
Benign
T;.;T;.;.;.
Sift4G
Uncertain
D;D;T;T;T;D
Polyphen
D;D;D;D;D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.